BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19174520)

  • 21. Mechanisms of chromosomal rearrangement in the human genome.
    Tsai AG; Lieber MR
    BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S1. PubMed ID: 20158866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis.
    Mahowald GK; Baron JM; Mahowald MA; Kulkarni S; Bredemeyer AL; Bassing CH; Sleckman BP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18339-44. PubMed ID: 19820166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms promoting translocations in editing and switching peripheral B cells.
    Wang JH; Gostissa M; Yan CT; Goff P; Hickernell T; Hansen E; Difilippantonio S; Wesemann DR; Zarrin AA; Rajewsky K; Nussenzweig A; Alt FW
    Nature; 2009 Jul; 460(7252):231-6. PubMed ID: 19587764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
    Ambinder RF; Griffin CA
    Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal location targets different MYC family gene members for oncogenic translocations.
    Gostissa M; Ranganath S; Bianco JM; Alt FW
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2265-70. PubMed ID: 19174520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.
    Difilippantonio MJ; Petersen S; Chen HT; Johnson R; Jasin M; Kanaar R; Ried T; Nussenzweig A
    J Exp Med; 2002 Aug; 196(4):469-80. PubMed ID: 12186839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching.
    Wang JH; Alt FW; Gostissa M; Datta A; Murphy M; Alimzhanov MB; Coakley KM; Rajewsky K; Manis JP; Yan CT
    J Exp Med; 2008 Dec; 205(13):3079-90. PubMed ID: 19064702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells.
    Rooney S; Sekiguchi J; Whitlow S; Eckersdorff M; Manis JP; Lee C; Ferguson DO; Alt FW
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2410-5. PubMed ID: 14983023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
    Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
    Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic Runx1-Myc axis in p53-deficient thymic lymphoma.
    Date Y; Taniuchi I; Ito K
    Gene; 2022 Apr; 819():146234. PubMed ID: 35114276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structure-specific nicking of small heteroduplexes by the RAG complex: implications for lymphoid chromosomal translocations.
    Raghavan SC; Gu J; Swanson PC; Lieber MR
    DNA Repair (Amst); 2007 Jun; 6(6):751-9. PubMed ID: 17307402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Myc oncoprotein as a therapeutic target for human cancer.
    Vita M; Henriksson M
    Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice.
    Yan CT; Kaushal D; Murphy M; Zhang Y; Datta A; Chen C; Monroe B; Mostoslavsky G; Coakley K; Gao Y; Mills KD; Fazeli AP; Tepsuporn S; Hall G; Mulligan R; Fox E; Bronson R; De Girolami U; Lee C; Alt FW
    Proc Natl Acad Sci U S A; 2006 May; 103(19):7378-83. PubMed ID: 16670198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus.
    Jung D; Giallourakis C; Mostoslavsky R; Alt FW
    Annu Rev Immunol; 2006; 24():541-70. PubMed ID: 16551259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations.
    Franco S; Gostissa M; Zha S; Lombard DB; Murphy MM; Zarrin AA; Yan C; Tepsuporn S; Morales JC; Adams MM; Lou Z; Bassing CH; Manis JP; Chen J; Carpenter PB; Alt FW
    Mol Cell; 2006 Jan; 21(2):201-14. PubMed ID: 16427010
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.